Request for Covid-19 Impact Assessment of this Report
The United States Pediatric Drugs and Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pediatric Drugs and Vaccines market, reaching US$ million by the year 2028. As for the Europe Pediatric Drugs and Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pediatric Drugs and Vaccines players cover Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), and Eli Lilly and Company (USA), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Drugs and Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Newborn
Infant
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pediatric Drugs and Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pediatric Drugs and Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Pediatric Drugs and Vaccines Segment by Type
2.2.1 Diphtheria
2.2.2 Influenza
2.2.3 Hepatitis
2.2.4 Pneumococcal Diseases
2.2.5 Meningococcal Diseases
2.2.6 Mumps
2.2.7 Others
2.3 Pediatric Drugs and Vaccines Sales by Type
2.3.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pediatric Drugs and Vaccines Sale Price by Type (2017-2022)
2.4 Pediatric Drugs and Vaccines Segment by Application
2.4.1 Newborn
2.4.2 Infant
2.4.3 Child
2.5 Pediatric Drugs and Vaccines Sales by Application
2.5.1 Global Pediatric Drugs and Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pediatric Drugs and Vaccines Sale Price by Application (2017-2022)
3 Global Pediatric Drugs and Vaccines by Company
3.1 Global Pediatric Drugs and Vaccines Breakdown Data by Company
3.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Pediatric Drugs and Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Pediatric Drugs and Vaccines Revenue by Company (2020-2022)
3.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Pediatric Drugs and Vaccines Sale Price by Company
3.4 Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Drugs and Vaccines Product Location Distribution
3.4.2 Players Pediatric Drugs and Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pediatric Drugs and Vaccines by Geographic Region
4.1 World Historic Pediatric Drugs and Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pediatric Drugs and Vaccines Annual Revenue by Geographic Region
4.2 World Historic Pediatric Drugs and Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Pediatric Drugs and Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pediatric Drugs and Vaccines Annual Revenue by Country/Region
4.3 Americas Pediatric Drugs and Vaccines Sales Growth
4.4 APAC Pediatric Drugs and Vaccines Sales Growth
4.5 Europe Pediatric Drugs and Vaccines Sales Growth
4.6 Middle East & Africa Pediatric Drugs and Vaccines Sales Growth
5 Americas
5.1 Americas Pediatric Drugs and Vaccines Sales by Country
5.1.1 Americas Pediatric Drugs and Vaccines Sales by Country (2017-2022)
5.1.2 Americas Pediatric Drugs and Vaccines Revenue by Country (2017-2022)
5.2 Americas Pediatric Drugs and Vaccines Sales by Type
5.3 Americas Pediatric Drugs and Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Drugs and Vaccines Sales by Region
6.1.1 APAC Pediatric Drugs and Vaccines Sales by Region (2017-2022)
6.1.2 APAC Pediatric Drugs and Vaccines Revenue by Region (2017-2022)
6.2 APAC Pediatric Drugs and Vaccines Sales by Type
6.3 APAC Pediatric Drugs and Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pediatric Drugs and Vaccines by Country
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Country (2017-2022)
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2017-2022)
7.2 Europe Pediatric Drugs and Vaccines Sales by Type
7.3 Europe Pediatric Drugs and Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediatric Drugs and Vaccines by Country
8.1.1 Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Pediatric Drugs and Vaccines Sales by Type
8.3 Middle East & Africa Pediatric Drugs and Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines
10.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
10.4 Industry Chain Structure of Pediatric Drugs and Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pediatric Drugs and Vaccines Distributors
11.3 Pediatric Drugs and Vaccines Customer
12 World Forecast Review for Pediatric Drugs and Vaccines by Geographic Region
12.1 Global Pediatric Drugs and Vaccines Market Size Forecast by Region
12.1.1 Global Pediatric Drugs and Vaccines Forecast by Region (2023-2028)
12.1.2 Global Pediatric Drugs and Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pediatric Drugs and Vaccines Forecast by Type
12.7 Global Pediatric Drugs and Vaccines Forecast by Application
13 Key Players Analysis
13.1 Merck & Co., Inc. (USA)
13.1.1 Merck & Co., Inc. (USA) Company Information
13.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offered
13.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck & Co., Inc. (USA) Main Business Overview
13.1.5 Merck & Co., Inc. (USA) Latest Developments
13.2 Abbott Laboratories (USA)
13.2.1 Abbott Laboratories (USA) Company Information
13.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offered
13.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Laboratories (USA) Main Business Overview
13.2.5 Abbott Laboratories (USA) Latest Developments
13.3 Amgen, Inc. (USA)
13.3.1 Amgen, Inc. (USA) Company Information
13.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
13.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Amgen, Inc. (USA) Main Business Overview
13.3.5 Amgen, Inc. (USA) Latest Developments
13.4 Eli Lilly and Company (USA)
13.4.1 Eli Lilly and Company (USA) Company Information
13.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offered
13.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly and Company (USA) Main Business Overview
13.4.5 Eli Lilly and Company (USA) Latest Developments
13.5 F. Hoffmann-La Roche Ltd (Switzerland)
13.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information
13.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offered
13.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments
13.6 Genentech, Inc. (USA)
13.6.1 Genentech, Inc. (USA) Company Information
13.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
13.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Genentech, Inc. (USA) Main Business Overview
13.6.5 Genentech, Inc. (USA) Latest Developments
13.7 GlaxoSmithKline plc. (UK)
13.7.1 GlaxoSmithKline plc. (UK) Company Information
13.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offered
13.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GlaxoSmithKline plc. (UK) Main Business Overview
13.7.5 GlaxoSmithKline plc. (UK) Latest Developments
13.8 Janssen Biologics B.V. (USA)
13.8.1 Janssen Biologics B.V. (USA) Company Information
13.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offered
13.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Janssen Biologics B.V. (USA) Main Business Overview
13.8.5 Janssen Biologics B.V. (USA) Latest Developments
13.9 Actelion Pharmaceuticals
13.9.1 Actelion Pharmaceuticals Company Information
13.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offered
13.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Actelion Pharmaceuticals Main Business Overview
13.9.5 Actelion Pharmaceuticals Latest Developments
13.10 AstraZeneca Plc. (UK)
13.10.1 AstraZeneca Plc. (UK) Company Information
13.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offered
13.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 AstraZeneca Plc. (UK) Main Business Overview
13.10.5 AstraZeneca Plc. (UK) Latest Developments
13.11 Boehringer Ingelheim GmbH (Germany)
13.11.1 Boehringer Ingelheim GmbH (Germany) Company Information
13.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offered
13.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Boehringer Ingelheim GmbH (Germany) Main Business Overview
13.11.5 Boehringer Ingelheim GmbH (Germany) Latest Developments
13.12 Bristol-Myers Squibb Company (USA)
13.12.1 Bristol-Myers Squibb Company (USA) Company Information
13.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offered
13.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bristol-Myers Squibb Company (USA) Main Business Overview
13.12.5 Bristol-Myers Squibb Company (USA) Latest Developments
13.13 Allergan, Inc. (USA)
13.13.1 Allergan, Inc. (USA) Company Information
13.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
13.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Allergan, Inc. (USA) Main Business Overview
13.13.5 Allergan, Inc. (USA) Latest Developments
13.14 Novartis AG (Switzerland)
13.14.1 Novartis AG (Switzerland) Company Information
13.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offered
13.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Novartis AG (Switzerland) Main Business Overview
13.14.5 Novartis AG (Switzerland) Latest Developments
13.15 Novo Nordisk A/S (Denmark)
13.15.1 Novo Nordisk A/S (Denmark) Company Information
13.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offered
13.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Novo Nordisk A/S (Denmark) Main Business Overview
13.15.5 Novo Nordisk A/S (Denmark) Latest Developments
13.16 Pfizer, Inc. (USA)
13.16.1 Pfizer, Inc. (USA) Company Information
13.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
13.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Pfizer, Inc. (USA) Main Business Overview
13.16.5 Pfizer, Inc. (USA) Latest Developments
13.17 Sanofi S.A (France)
13.17.1 Sanofi S.A (France) Company Information
13.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offered
13.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sanofi S.A (France) Main Business Overview
13.17.5 Sanofi S.A (France) Latest Developments
13.18 Shionogi Inc. (USA)
13.18.1 Shionogi Inc. (USA) Company Information
13.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offered
13.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Shionogi Inc. (USA) Main Business Overview
13.18.5 Shionogi Inc. (USA) Latest Developments
13.19 Takeda
13.19.1 Takeda Company Information
13.19.2 Takeda Pediatric Drugs and Vaccines Product Offered
13.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Takeda Main Business Overview
13.19.5 Takeda Latest Developments
14 Research Findings and Conclusion
Table 1. Pediatric Drugs and Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pediatric Drugs and Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diphtheria
Table 4. Major Players of Influenza
Table 5. Major Players of Hepatitis
Table 6. Major Players of Pneumococcal Diseases
Table 7. Major Players of Meningococcal Diseases
Table 8. Major Players of Mumps
Table 9. Major Players of Others
Table 10. Global Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
Table 11. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)
Table 12. Global Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & ($ million)
Table 13. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2022)
Table 14. Global Pediatric Drugs and Vaccines Sale Price by Type (2017-2022) & (USD/Kg)
Table 15. Global Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
Table 16. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)
Table 17. Global Pediatric Drugs and Vaccines Revenue by Application (2017-2022)
Table 18. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2022)
Table 19. Global Pediatric Drugs and Vaccines Sale Price by Application (2017-2022) & (USD/Kg)
Table 20. Global Pediatric Drugs and Vaccines Sales by Company (2020-2022) & (Kg)
Table 21. Global Pediatric Drugs and Vaccines Sales Market Share by Company (2020-2022)
Table 22. Global Pediatric Drugs and Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2020-2022)
Table 24. Global Pediatric Drugs and Vaccines Sale Price by Company (2020-2022) & (USD/Kg)
Table 25. Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution and Sales Area
Table 26. Players Pediatric Drugs and Vaccines Products Offered
Table 27. Pediatric Drugs and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Pediatric Drugs and Vaccines Sales by Geographic Region (2017-2022) & (Kg)
Table 31. Global Pediatric Drugs and Vaccines Sales Market Share Geographic Region (2017-2022)
Table 32. Global Pediatric Drugs and Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Pediatric Drugs and Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Pediatric Drugs and Vaccines Sales by Country/Region (2017-2022) & (Kg)
Table 35. Global Pediatric Drugs and Vaccines Sales Market Share by Country/Region (2017-2022)
Table 36. Global Pediatric Drugs and Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Pediatric Drugs and Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)
Table 39. Americas Pediatric Drugs and Vaccines Sales Market Share by Country (2017-2022)
Table 40. Americas Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country (2017-2022)
Table 42. Americas Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
Table 43. Americas Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)
Table 44. Americas Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
Table 45. Americas Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)
Table 46. APAC Pediatric Drugs and Vaccines Sales by Region (2017-2022) & (Kg)
Table 47. APAC Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022)
Table 48. APAC Pediatric Drugs and Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Pediatric Drugs and Vaccines Revenue Market Share by Region (2017-2022)
Table 50. APAC Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
Table 51. APAC Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)
Table 52. APAC Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
Table 53. APAC Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)
Table 54. Europe Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)
Table 55. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2017-2022)
Table 56. Europe Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2017-2022)
Table 58. Europe Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
Table 59. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)
Table 60. Europe Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
Table 61. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)
Table 63. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
Table 67. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
Table 69. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Pediatric Drugs and Vaccines
Table 71. Key Market Challenges & Risks of Pediatric Drugs and Vaccines
Table 72. Key Industry Trends of Pediatric Drugs and Vaccines
Table 73. Pediatric Drugs and Vaccines Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Pediatric Drugs and Vaccines Distributors List
Table 76. Pediatric Drugs and Vaccines Customer List
Table 77. Global Pediatric Drugs and Vaccines Sales Forecast by Region (2023-2028) & (Kg)
Table 78. Global Pediatric Drugs and Vaccines Sales Market Forecast by Region
Table 79. Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Pediatric Drugs and Vaccines Sales Forecast by Country (2023-2028) & (Kg)
Table 82. Americas Pediatric Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Pediatric Drugs and Vaccines Sales Forecast by Region (2023-2028) & (Kg)
Table 84. APAC Pediatric Drugs and Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2023-2028) & (Kg)
Table 86. Europe Pediatric Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Pediatric Drugs and Vaccines Sales Forecast by Country (2023-2028) & (Kg)
Table 88. Middle East & Africa Pediatric Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2023-2028) & (Kg)
Table 90. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2023-2028) & (Kg)
Table 94. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 97. Merck & Co., Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 99. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. Merck & Co., Inc. (USA) Main Business
Table 101. Merck & Co., Inc. (USA) Latest Developments
Table 102. Abbott Laboratories (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offered
Table 104. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Abbott Laboratories (USA) Main Business
Table 106. Abbott Laboratories (USA) Latest Developments
Table 107. Amgen, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 109. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Amgen, Inc. (USA) Main Business
Table 111. Amgen, Inc. (USA) Latest Developments
Table 112. Eli Lilly and Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offered
Table 114. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. Eli Lilly and Company (USA) Main Business
Table 116. Eli Lilly and Company (USA) Latest Developments
Table 117. F. Hoffmann-La Roche Ltd (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offered
Table 119. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 120. F. Hoffmann-La Roche Ltd (Switzerland) Main Business
Table 121. F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments
Table 122. Genentech, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 124. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 125. Genentech, Inc. (USA) Main Business
Table 126. Genentech, Inc. (USA) Latest Developments
Table 127. GlaxoSmithKline plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offered
Table 129. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 130. GlaxoSmithKline plc. (UK) Main Business
Table 131. GlaxoSmithKline plc. (UK) Latest Developments
Table 132. Janssen Biologics B.V. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offered
Table 134. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 135. Janssen Biologics B.V. (USA) Main Business
Table 136. Janssen Biologics B.V. (USA) Latest Developments
Table 137. Actelion Pharmaceuticals Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offered
Table 139. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 140. Actelion Pharmaceuticals Main Business
Table 141. Actelion Pharmaceuticals Latest Developments
Table 142. AstraZeneca Plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offered
Table 144. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 145. AstraZeneca Plc. (UK) Main Business
Table 146. AstraZeneca Plc. (UK) Latest Developments
Table 147. Boehringer Ingelheim GmbH (Germany) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offered
Table 149. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 150. Boehringer Ingelheim GmbH (Germany) Main Business
Table 151. Boehringer Ingelheim GmbH (Germany) Latest Developments
Table 152. Bristol-Myers Squibb Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offered
Table 154. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 155. Bristol-Myers Squibb Company (USA) Main Business
Table 156. Bristol-Myers Squibb Company (USA) Latest Developments
Table 157. Allergan, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 159. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 160. Allergan, Inc. (USA) Main Business
Table 161. Allergan, Inc. (USA) Latest Developments
Table 162. Novartis AG (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offered
Table 164. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 165. Novartis AG (Switzerland) Main Business
Table 166. Novartis AG (Switzerland) Latest Developments
Table 167. Novo Nordisk A/S (Denmark) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offered
Table 169. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 170. Novo Nordisk A/S (Denmark) Main Business
Table 171. Novo Nordisk A/S (Denmark) Latest Developments
Table 172. Pfizer, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 173. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 174. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 175. Pfizer, Inc. (USA) Main Business
Table 176. Pfizer, Inc. (USA) Latest Developments
Table 177. Sanofi S.A (France) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 178. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offered
Table 179. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 180. Sanofi S.A (France) Main Business
Table 181. Sanofi S.A (France) Latest Developments
Table 182. Shionogi Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 183. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offered
Table 184. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 185. Shionogi Inc. (USA) Main Business
Table 186. Shionogi Inc. (USA) Latest Developments
Table 187. Takeda Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 188. Takeda Pediatric Drugs and Vaccines Product Offered
Table 189. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 190. Takeda Main Business
Table 191. Takeda Latest Developments
List of Figures
Figure 1. Picture of Pediatric Drugs and Vaccines
Figure 2. Pediatric Drugs and Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Drugs and Vaccines Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Pediatric Drugs and Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pediatric Drugs and Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diphtheria
Figure 10. Product Picture of Influenza
Figure 11. Product Picture of Hepatitis
Figure 12. Product Picture of Pneumococcal Diseases
Figure 13. Product Picture of Meningococcal Diseases
Figure 14. Product Picture of Mumps
Figure 15. Product Picture of Others
Figure 16. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2021
Figure 17. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2022)
Figure 18. Pediatric Drugs and Vaccines Consumed in Newborn
Figure 19. Global Pediatric Drugs and Vaccines Market: Newborn (2017-2022) & (Kg)
Figure 20. Pediatric Drugs and Vaccines Consumed in Infant
Figure 21. Global Pediatric Drugs and Vaccines Market: Infant (2017-2022) & (Kg)
Figure 22. Pediatric Drugs and Vaccines Consumed in Child
Figure 23. Global Pediatric Drugs and Vaccines Market: Child (2017-2022) & (Kg)
Figure 24. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)
Figure 25. Global Pediatric Drugs and Vaccines Revenue Market Share by Application in 2021
Figure 26. Pediatric Drugs and Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Pediatric Drugs and Vaccines Revenue Market Share by Company in 2021
Figure 28. Global Pediatric Drugs and Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Pediatric Drugs and Vaccines Revenue Market Share by Geographic Region in 2021
Figure 30. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022)
Figure 31. Global Pediatric Drugs and Vaccines Revenue Market Share by Country/Region in 2021
Figure 32. Americas Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)
Figure 33. Americas Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. APAC Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)
Figure 35. APAC Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)
Figure 36. Europe Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)
Figure 37. Europe Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)
Figure 39. Middle East & Africa Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)
Figure 40. Americas Pediatric Drugs and Vaccines Sales Market Share by Country in 2021
Figure 41. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country in 2021
Figure 42. United States Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Pediatric Drugs and Vaccines Sales Market Share by Region in 2021
Figure 47. APAC Pediatric Drugs and Vaccines Revenue Market Share by Regions in 2021
Figure 48. China Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Pediatric Drugs and Vaccines Sales Market Share by Country in 2021
Figure 55. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country in 2021
Figure 56. Germany Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country in 2021
Figure 63. Egypt Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines in 2021
Figure 69. Manufacturing Process Analysis of Pediatric Drugs and Vaccines
Figure 70. Industry Chain Structure of Pediatric Drugs and Vaccines
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...